BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
PRODID://AGT//511701
BEGIN:VEVENT
DTSTAMP:20260422T135041
VTIMEZONE:America/New_York
DTSTART:20260319T170000Z
DTEND:20260319T180000Z
UID:511701
SUMMARY:Webinar: Sex Discrepant Results in the Laboratory
LOCATION:
DESCRIPTION:Webinar: Sex Discrepant Results in the Laboratory\n\n03/19/26 01:00 PM EST\n - 03/19/26 02:00 PM EST\Description:\nVirtual webinar provides 1.0 CE credits. Complementary registration available to AGT members. Non-members can receive CE credits for $20.\nEvents will be recorded and converted to self-study for self-paced format, available at a later date . Fees may be modified based on format.\n\n\nPresented by:\nRikki H. Pittman CG(ASCP)\nClinical Cytogenetic Technologist Specialist\nUniversity of Washington\n\nDescription:\nThere has been a significant increase in sex discrepant result in the laboratory due to transgender patients. How should laboratories consider changing their protocols? How can providers and laboratories work together to provide the best patient care to the trans community?\n\nObjectives:\n\n	To Understand the causes of sex discrepant results in regard to gender identity.\n	Immediate steps for addressing sex discrepant results.\n	How providers can help provide information to eliminate sex discrepant results in regard to gender identity\n\n\n\n\n 
X-ALT-DESC;FMTTYPE=text/html:Webinar: Sex Discrepant Results in the Laboratory<br /><br />03/19/26 01:00 PM EST - 03/19/26 02:00 PM EST<br />Description:<br /><em>Virtual webinar provides 1.0 CE credits. Complementary registration available to AGT members. Non-members can receive CE credits for $20.<br />
Events will be recorded and converted to self-study for self-paced format, available at a later date . Fees may be modified based on format.</em><br />
<br />
<br />
<strong>Presented by:</strong><br />
Rikki H. Pittman CG(ASCP)<br />
Clinical Cytogenetic Technologist Specialist<br />
University of Washington<br />
<br />
<strong>Description:</strong><br />
There has been a significant increase in sex discrepant result in the laboratory due to transgender patients. How should laboratories consider changing their protocols? How can providers and laboratories work together to provide the best patient care to the trans community?<br />
<br />
<strong>Objectives:</strong>
<ul>
	<li>To Understand the causes of sex discrepant results in regard to gender identity.</li>
	<li>Immediate steps for addressing sex discrepant results.</li>
	<li>How providers can help provide information to eliminate sex discrepant results in regard to gender identity</li>
</ul>
<br />
<br />
<br />
&nbsp;
PRIORITY:3
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-PT5M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR